Maximize efficiencies and minimize costs
There are a variety of successful processes that our teams follow when guiding client’s through transitional strategies. After carefully listening to your vision, we customize each process to deliver the best results that match your checklist of goals. Our collaboration with your internal and external vendor teams for design and engineering is critical to your and our ability to set realistic expectations for budgets, occupancy, and final validation.
Our clients that require new or expanding space benefit from our expertise in the following ways:
- Optimal location solutions for talent attraction, accessibility, operating costs, specialized requirements, incentives and more
- Negotiated occupancy cost savings
- Flexibility for changing circumstances, including rapid growth, unforeseen setbacks in trial results, M&A and more
- Favorable capital investment structure with landlords
- Protection from unrecognized exposures over the life of a lease
And our clients who own, develop or are converting buildings for life sciences use can accelerate the performance of their assets by capitalizing on our understanding of:
- Capitalization and credit of growing drug development companies
- Infrastructure and capital requirements of research lab and manufacturing facilities
- Life cycle factors shaping transaction structuring for life sciences users
Both occupiers and landlords can capitalize on the deep relationships our members have cultivated with partners across the life sciences ecosystem both nationally and in their local clusters including:
- Venture and private equity
- Design, engineering and construction
- Talent and recruitment
- Equipment and consumables
- State, local and municipal government
- Economic development
Whether you are looking for new lab or manufacturing space to support your growing operations or bringing a new life sciences property to market, Colliers’ Life Sciences Practice Group experts are here to partner with you to improve your outcome and accelerate your success.
Life Sciences brochure
Whether you are looking to lease or invest in a research center or life sciences property, or you need project management or construction management services, our team has the market knowledge and connections to ensure on-time and under-budget delivery of the most sophisticated projects.
Senior Director, Office Services
As the National Leader of Colliers Global Life Science Practice Group, I bring 43 years of commercial real estate experience and 22 years of experience focusing on life science real estate. My acquired knowledge in life science work has been on both the landlord (Wexford Science & Technology) and the tenant side within the industry.
I have experience with Advanced Therapeutic Medicinal Products, Parenteral Fill Finish, Solid Oral Dosage, Biologics, and Medical Device manufacturing facilities, as well as a solid background in Laboratory Research and Development/Pilot scale facilities and controlled environments. Through my work on local, regional and national site selection assignments, I have developed a firm grasp of the rigorous process required to meet the key search criteria of my clients.
My knowledge of market conditions and influences in the life sciences supports my ability to be creative in structuring the financial details of both lease and purchase transactions. My network of a wide variety of trusted advisors within the industry facilitates a regular flow of information about life science real estate trends, pricing, and comparable data for leasing and sales transactions.
Executive Vice President
Mr. Cole joined the Colliers International Urban Brokerage team in 2018. He has spent 30 years working in the industry, focusing on companies within the life science, pharmaceutical, biomanufacturing and technology industries. His practice involves creating effective real estate solutions for his clients, locally and globally, and landlord representation for primarily office and industrial properties.
Executive Vice President | Healthcare and Life Sciences
Joe joined Colliers International in 2012 to lead and grow Colliers’ Office Brokerage Division. Today he focuses on providing strategic solutions to local, national and global Health Care, Life Sciences and Corporate clients. Joe’s background in architecture, real estate development and financial analysis provides clients with an experienced professional and strategic leader who integrates complex factors to create successful results for clients
Joe is a Healthcare Fellow and serves on Colliers National Healthcare Services and Life Sciences Steering Committees.
Executive Managing Director
Charlie has more than 29 years of experience in commercial real estate and related fields, and has worked with a broad range of clients/tenants including Merrill Lynch, Integra LifeSciences, Deutsche Bank AG, BASF, Biomet, Kohlberg Kravis Roberts (KKR), KKR/Capstone, John Wiley and Sons, Maher Terminals, AIG, Marsh & McLennan, Mobil, Sprint, Siemens, AON, Fidelity Investments, Lehman Brothers, PNC Bank, Prudential, Sanofi-Aventis, Coca-Cola and Aetna/US Healthcare, Celgene, Celularity, Cellectis. Additionally, he has represented institutional ownership in the disposition and acquisition of land, buildings, build-to-suits and large-scale lease transactions.
Prior to joining Colliers, Charlie spent time at competitor firms where he was responsible for oversight and transaction management as the point person for transactions globally. He also oversaw an 8.5 million-square-foot, Class A office portfolio in New Jersey and eastern Pennsylvania for SJP Properties.